Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.
about
Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancyMicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentMicroRNAs and benign biliary tract diseasesArsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stressmiR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer CellsMicroRNAs in Cholangiopathies.Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.Systems toxicology approaches enable mechanistic comparison of spontaneous and cigarette smoke-related lung tumor development in the A/J mouse model.Prognostic significance of miR-126 in various cancers: a meta-analysis.Age-related changes in microRNA levels in serumHuman adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsAnalysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.Therapeutic effects of serum extracellular vesicles in liver fibrosis.
P2860
Q26767120-971E178B-B024-4DC9-858C-E534A217F85CQ26783579-1F8130FB-3A5D-4250-BC22-EF0A6E994BD1Q26865762-B07614A8-22B6-4C33-875A-3D6BD4B0E029Q28389940-DA6A06EA-A5AD-499A-A4BB-06ACCFF9CB14Q28588589-D93F4C91-4AF0-4160-8C35-D15FEF074C5AQ33991899-3C3502E9-C088-44F6-816C-1DB55E19DBB8Q34200081-2777D324-BA62-494E-9454-46BFA43882F6Q35544302-39133B07-A29E-4E49-9375-651FF3788FECQ35594350-0CDCF86B-6031-4DDA-A227-A5B3C06C1DDAQ36858228-C011EFF5-69D1-49C5-9082-716E4A9E92DDQ37338097-1EC3A077-F7D5-49F8-8836-972FE9B9AE21Q37483696-8D212E61-A9F2-4749-BE95-DF3ADC8E9A8FQ37706763-4EE3C629-EC4E-4458-9C50-CE5AE8FEE600Q39259431-49870B49-9FA3-4C8B-AFD8-F193D4E4F52CQ39443955-0093AD86-83F1-469A-A815-E66EA4A1F7D3Q53099936-926C8CF2-0F35-4410-93E9-74C62CDC5A2DQ54091049-171308B2-70E7-4C18-AA40-787D96A53FF2
P2860
Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@ast
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@en
type
label
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@ast
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@en
prefLabel
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@ast
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@en
P2093
P2860
P1476
Concomitant dysregulation of m ...... n resected cholangiocarcinoma.
@en
P2093
Amy Collins
Jinmai Jiang
Jon C Henry
Mark Bloomston
Megan E McNally
Sylwia E Wojcik
Thomas Schmittgen
P2860
P304
P356
10.1111/J.1477-2574.2012.00523.X
P577
2012-07-04T00:00:00Z